Infiuss health
Infiuss Health is developing an AI-powered Clinical Trial Copilot designed to transform how modern clinical trials and medical research are conducted. Our Copilot PROBE is built on a domain-specific Retrieval-Augmented Generation (RAG) framework, specially adapted for clinical trials. This ensures deep contextual understanding, faster decision-making, and smarter insights across the entire clinical trial lifecycle. With Infiuss Health’s cutting-edge AI capabilities, researchers and sponsors can navigate the complexities of clinical trials more effectively than ever before. From protocol design, site and patient management and data collection and analysis, our solution serves as a reliable, intelligent assistant—empowering teams to reduce delays, mitigate risks, and optimize outcomes.
Infiuss health
Infiuss Health is developing an AI-powered Clinical Trial Copilot designed to transform how modern clinical trials and medical research are conducted. Our Copilot PROBE is built on a domain-specific Retrieval-Augmented Generation (RAG) framework, specially adapted for clinical trials. This ensures deep contextual understanding, faster decision-making, and smarter insights across the entire clinical trial lifecycle. With Infiuss Health’s cutting-edge AI capabilities, researchers and sponsors can navigate the complexities of clinical trials more effectively than ever before. From protocol design, site and patient management and data collection and analysis, our solution serves as a reliable, intelligent assistant—empowering teams to reduce delays, mitigate risks, and optimize outcomes.
TL;DR
What they do: AI-powered Clinical Trial Copilot (Copilot PROBE) and digital patient twins for clinical trial simulation and optimization
Founded / HQ: Founded Feb 1, 2021 — San Francisco, California, United States
Latest funding: Series A announced 2025-03-01; Series A investors include Exitfund and Evolution Ventures; pre-money valuation listed $18M
Reported total funding: 3730000.00 USD
Founder & CEO: Melissa Jane BIME
Team size (reported): 8 employees
Company Overview
Problem Domain
Modern clinical trials and medical research, including protocol design, site and patient management, data collection and analysis, and pharmaceutical simulation via digital patient twins.
Founded
2021
Industry
Healthcare / Pharma AI
Funding Track Record
Series A listed with a pre-money valuation of $18M; Crunchbase indicates five funding rounds in total.
Investor Signal
“Investors include Exitfund and Evolution Ventures for the Series A; Crunchbase lists 17 total investors.”